A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration (4FRONT-1)
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
4D Molecular Therapeutics
Start Date
September 9, 2025
End Date
May 31, 2030
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
4D Molecular Therapeutics
Start Date
September 9, 2025
End Date
May 31, 2030